Concepedia

Swen Seeland

SS

Statistics

Publications

5

Citations

118

H-Index

5

Active since

2013

Affiliations

Actelion (Switzerland)(Current)

University of Basel

Idorsia (Switzerland)

Technische Hochschule Mannheim

Swen Seeland is an author at Actelion (Switzerland) specializing in drug analysis, bioanalysis, and drug discovery.

ORCID

Top concepts

Publications per year

2013–2019

5

Publications

5

ATP‐induced cellular stress and mitochondrial toxicity in cells expressing purinergic P2X7 receptor

Swen Seeland, Hélène Kettiger, Mark Murphy et al. · Pharmacology Research & Perspectives · 2015 · 38 citations · Full text

Discovery of Novel Inhibitors of LpxC Displaying Potent in Vitro Activity against Gram-Negative Bacteria

Jean‐Philippe Surivet, Philippe Panchaud, Jean‐Luc Specklin et al. · Journal of Medicinal Chemistry · 2019 · 34 citations

Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration

Philippe Panchaud, Jean‐Philippe Surivet, Stefan Diethelm et al. · Journal of Medicinal Chemistry · 2019 · 16 citations · Full text

A cell-based, multiparametric sensor approach characterises drug-induced cytotoxicity in human liver HepG2 cells

Swen Seeland, Michael Török, Hélène Kettiger et al. · Toxicology in Vitro · 2013 · 15 citations

, , +12

The metabolism and drug–drug interaction potential of the selective prostacyclin receptor agonist selexipag

Carmela Gnerre, Jérôme Segrestaa, Swen Seeland et al. · Xenobiotica · 2017 · 15 citations

1–5 of 5